Status of serum VEGF and ICAM-1 and its association with external limiting membrane and inner segment-outer segment junction disruption in type 2 diabetes mellitus.
about
Molecular Markers of Diabetic Retinopathy: Potential Screening Tool of the Future?Photoreceptor inner segment ellipsoid band integrity on spectral domain optical coherence tomographyCross Talk between Lipid Metabolism and Inflammatory Markers in Patients with Diabetic Retinopathy.Regulatory SNPs Alter the Gene Expression of Diabetic Retinopathy Associated Secretary Factors.Systemic Associations with Residual Subretinal Fluid after Ranibizumab in Diabetic Macular Edema.Interindividual Heterogeneity of Hypoxic Response of Vascular Endothelial Growth Factor and Intercellular Adhesive Molecule-1 in Monocytes from Diabetic Patients.Quercetin Mitigates Inflammatory Responses Induced by Vascular Endothelial Growth Factor in Mouse Retinal Photoreceptor Cells through Suppression of Nuclear Factor Kappa B.Automated detection of photoreceptor disruption in mild diabetic retinopathy on volumetric optical coherence tomography.How relevant are vascular endothelial growth factor and intercellular adhesion molecule in the systemic capillary leak syndrome of psoriasis?The potential of spectral domain optical coherence tomography imaging based retinal biomarkers.Resistive index of ophthalmic artery correlates with retinal pigment epithelial alterations on spectral domain optical coherence tomography in diabetic retinopathy.Role of Inflammation in Diabetic Retinopathy.Correlation of biomarkers thiobarbituric acid reactive substance, nitric oxide and central subfield and cube average thickness in diabetic retinopathy: a cross-sectional study.Association between the expression of vascular endothelial growth factors and metabolic syndrome or its components: a systematic review and meta-analysisCentral subfield thickness and cube average thickness as bioimaging biomarkers for ellipsoid zone disruption in diabetic retinopathyThe Oxidative Stress and Mitochondrial Dysfunction during the Pathogenesis of Diabetic Retinopathy
P2860
Q26745555-43AB825A-D825-487A-AAD1-C917959F0D7FQ27021797-67E54DBB-273D-40A0-B818-546D240C5901Q35942012-133D13D4-DCE5-4D2D-A3FA-EB51F7F97224Q37263517-6CC72E89-94E7-4BF2-BDB0-B555D5C543CDQ41341809-C8E5466E-FBC4-4827-996E-B6151E81585FQ42355611-B45C8463-8202-47AE-904B-AC47BDD0C75CQ47125046-C0AF274D-E438-4666-9D0A-21ED35FF8661Q47137147-B0D6AD93-C9F2-47B0-A87C-4863BB9A3BECQ49824772-4DF6B0C0-091A-43B6-A934-20026AA3ED89Q50791101-06E83FBB-8D68-4147-B1BB-2CDF15D0FE31Q52587103-BC83155B-49A4-42A6-A18B-431F0D90FF0FQ52642996-059876C0-0B95-4EA4-A029-867DB056A30AQ55124014-57E1D1C4-58D3-4EA1-A66B-6869306BEB5EQ58007150-0261321C-618E-4542-A241-8BD6018B75FAQ58616565-18D48E2A-2454-42AB-BD53-EEE8EE71BC6BQ58762667-35704E93-AFE5-421F-A499-4BFDE8B54813
P2860
Status of serum VEGF and ICAM-1 and its association with external limiting membrane and inner segment-outer segment junction disruption in type 2 diabetes mellitus.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Status of serum VEGF and ICAM- ...... n in type 2 diabetes mellitus.
@en
Status of serum VEGF and ICAM- ...... n in type 2 diabetes mellitus.
@nl
type
label
Status of serum VEGF and ICAM- ...... n in type 2 diabetes mellitus.
@en
Status of serum VEGF and ICAM- ...... n in type 2 diabetes mellitus.
@nl
prefLabel
Status of serum VEGF and ICAM- ...... n in type 2 diabetes mellitus.
@en
Status of serum VEGF and ICAM- ...... n in type 2 diabetes mellitus.
@nl
P2093
P2860
P1433
P1476
Status of serum VEGF and ICAM- ...... n in type 2 diabetes mellitus.
@en
P2093
Astha Jain
Carsten H Meyer
Rajendra K Shukla
Sandeep Saxena
Vinay K Khanna
P2860
P304
P577
2013-08-04T00:00:00Z